ABIVAX

Serial Number 97400997
Registration 7302315
700

Registration Progress

Application Filed
May 9, 2022
Under Examination
Approved for Publication
Jun 27, 2023
Published for Opposition
Jun 27, 2023
Registered
Feb 13, 2024

Trademark Image

ABIVAX

Basic Information

Serial Number
97400997
Registration Number
7302315
Filing Date
May 9, 2022
Registration Date
February 13, 2024
Published for Opposition
June 27, 2023
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 13, 2024
Registration
Registered
Classes
042

Rights Holder

ABIVAX

33
Address
7-11 BOULEVARD HAUSSMANN
PARIS 75009
FR

Ownership History

Abivax SA

Original Applicant
03
Paris FR

Abivax SA

Owner at Publication
03
Paris FR

Abivax SA

Original Registrant
03
Paris FR

ABIVAX

New Owner After Registration #1
33
PARIS FR

Legal Representation

Attorney
Glenn Gundersen

USPTO Deadlines

Next Deadline
1514 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240213)
Due Date
February 13, 2030
Grace Period Ends
August 13, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

23 events
Date Code Type Description Documents
Mar 27, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Feb 23, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 23, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 23, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 23, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Feb 23, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Feb 13, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Feb 13, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 4, 2024 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Jul 24, 2023 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Jun 27, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 27, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 7, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 25, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 18, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 17, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 17, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 27, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 27, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 27, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 27, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
May 13, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 12, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Pharmaceutical research and development; drug development and discovery services; medical and scientific research; providing medical and scientific research information services
First Use Anywhere: Mar 1, 2015
First Use in Commerce: Mar 1, 2015

Classification

International Classes
042